George Golumbeski

George Golumbeski

Président chez SHATTUCK LABS, INC.

Fortune : 303 648 $ au 31/10/2026

68 ans
Health Technology
Commercial Services
Finance

Profil

George S.
Golumbeski
is currently Chairman at Carrick Therapeutics UK Ltd., Verseau Therapeutics, Inc., Actio Biosciences, Inc., National Audubon Society, Inc., Carrick Therapeutics, Inc., and Acumen Pharmaceuticals, Inc. He serves as Independent Chairman at Shattuck Labs, Inc., Non-Executive Director at Faron Pharmaceuticals Oy, and Director at Corbus Pharmaceuticals, Inc., BlackThorn Therapeutics, Inc., Tusk Therapeutics Ltd., and Peptone Ltd. He is a Trustee at Keck Graduate Institute of Applied Life Sciences, Partner at Droia Ventures, and Venture Advisor at Vertex Ventures HC.
Former roles include Chief Executive Officer at Nabriva Therapeutics GmbH, Chairman at Aura Biosciences, Inc., BioSight Ltd., and Ananke Therapeutics, Inc., Deputy Chairman-Supervisory Board at MorphoSys AG, Independent Director at SAGE Therapeutics, Inc., Independent Director at Acceleron Pharma, Inc., Independent Director at Enanta Pharmaceuticals, Inc., President & Director at GRAIL, Inc., Director at Corbus Pharmaceuticals Holdings, Inc., Director-Business Development at Pierce Biotechnology, Inc., Vice President & Director-Corporate Development at Schwarz Pharma, Inc., Senior Director-Licensing at EMD Pharmaceuticals, Inc., Vice President-Business Development at Elan Pharmaceuticals LLC, VP-Business Development, Licensing & Strategy at Novartis Oncology, Inc., Executive Vice President-Innovation at Celgene Corp., Manager-Technology Acquisition at Promega Corp., and Independent Director at Mural Oncology Plc.
Education includes a doctorate from the University of Wisconsin conferred in 1985 and an undergraduate degree from the University of Virginia conferred in 1979.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
29/05/2026 54 613 ( 0,05 % ) 303 648 $ 31/10/2026
03/06/2026 0 ( -.--% ) - $ 31/10/2026

Postes actifs de George Golumbeski

SociétésPosteDébut
SHATTUCK LABS, INC. Président 22/10/2021
ACUMEN PHARMACEUTICALS, INC. Président 06/11/2025
FARON PHARMACEUTICALS OY Directeur/Membre du Conseil 05/05/2026
Président 28/09/2024
Président 11/10/2018
Président 20/10/2019
Président -
Président -
Directeur/Membre du Conseil 01/01/2013
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de George Golumbeski

SociétésPosteFin
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de George Golumbeski

Formation de George Golumbeski

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

79

Relations au 1er degré

39

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées39

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. George Golumbeski
🔇